2004
DOI: 10.1183/09031936.04.000105403
|View full text |Cite
|
Sign up to set email alerts
|

Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis

Abstract: Nonsyncytium inducing, macrophage tropic HIV strains predominate in the course of active tuberculosis (TB). The present study assesses the expression of CCR5 in CD4+ T-lymphocytes from blood and bronchoalveolar lavage (BAL) of TB patients, non-TB lung disease controls and healthy controls. Memory (CD45RO+), recently activated (CD69+), proliferating (Ki67+) CCR5+ or CCR3+ CD4+ T-lymphocytes were determined by multiparametric flow cytometry analysis. Results show that BAL CD4+ T-lymphocytes expressing CCR5 or CC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
17
1

Year Published

2005
2005
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 29 publications
3
17
1
Order By: Relevance
“…33 Our findings established CCR5-utilizing variants in both plasma and tissue in all but two sequences; this is consistent with previous studies of HIV-1 subtype C infections showing minimal corrector switch from CCR5 to CXCR4 even in the context of late stage AIDS and coinfections such as pulmonary TB. 28 Phenotypic studies may be warranted since genotype does not always accurately predict coreceptor utilization and subtle differences in usage of CD4 and coreceptors have been noted with CSF-derived and other viral isolates.…”
Section: Discussionsupporting
confidence: 80%
“…33 Our findings established CCR5-utilizing variants in both plasma and tissue in all but two sequences; this is consistent with previous studies of HIV-1 subtype C infections showing minimal corrector switch from CCR5 to CXCR4 even in the context of late stage AIDS and coinfections such as pulmonary TB. 28 Phenotypic studies may be warranted since genotype does not always accurately predict coreceptor utilization and subtle differences in usage of CD4 and coreceptors have been noted with CSF-derived and other viral isolates.…”
Section: Discussionsupporting
confidence: 80%
“…There was also an increase in the proportion of CD4 + T cells co-expressing CCR5 + and CXCR3 + in the TB-IRIS group compared with the non-TB-IRIS group at the week 2 visit after ART initiation, but this did not persist. It has been previously shown that M. tuberculosis infection of monocyte-derived macrophages increases CCR5 + expression on T cells when compared with the CXCR3 + expression and that CCR5 + CD4 + T cells accumulate in the lung at higher rates during the course of active TB 37. Given the association of CCR5 + T cells with M. tuberculosis disease, and our finding of increased CCR5 + CD4 + T cells in TB-IRIS, we suggest that CCR5 inhibitor therapy should be considered as a therapeutic strategy to prevent TB-IRIS in HIV-infected patients with treated TB who commence ART.…”
Section: Discussionmentioning
confidence: 99%
“…It is expressed on granulocytes, dendritic cells, macrophages, CD8 + cells, memory CD4 + cells, and stromal cells and at high levels on Th1 lymphocytes (29)(30)(31)(32)(33). CCR5 plays a critical role in Th1 inflammation and immunity, where it is required for the successful control of a variety of infectious agents, including tuberculosis, cryptococcus, and toxoplasma (29,31,(34)(35)(36) and is expressed in exaggerated quantities in Tc1-dominated responses, including those in tuberculosis, sarcoidosis, Wegner granulomatosis, rheumatoid arthritis, periodontitis, and acute and chronic transplant rejection (7,31,34,(37)(38)(39)(40)(41). In these responses, CCR5 plays an important role in the pathogenesis of tissue inflammation, protease production, tissue remodeling (41), and local cell death responses (42,43).…”
Section: Introductionmentioning
confidence: 99%